Balance Sheet
Cash Flow Statement
AcquisitionsAmortization of Deferred ChargesAmortizatization of IntangiblesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Accured ExpensesChange in CashChange in IntangiblesChange in InventoryChange in ReceivablesDepreciation & Amortization (CF)Free Cash FlowGains from Investment SecuritiesLong-Term Debt RepaymentsNet Cash FlowNet IncomeOther Working Capital ChangesShare-based CompensationShort-Term Debt issuances
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Cumberland Pharmaceuticals (CPIX) Change in Cash (2016 - 2025)

Cumberland Pharmaceuticals' Change in Cash history spans 16 years, with the latest figure at -$3.8 million for Q4 2025.

  • For Q4 2025, Change in Cash fell 851.27% year-over-year to -$3.8 million; the TTM value through Dec 2025 reached -$6.5 million, down 1723.94%, while the annual FY2025 figure was -$6.5 million, 1723.94% down from the prior year.
  • Change in Cash for Q4 2025 was -$3.8 million at Cumberland Pharmaceuticals, down from -$890536.0 in the prior quarter.
  • Across five years, Change in Cash topped out at $1.3 million in Q3 2022 and bottomed at -$9.8 million in Q1 2022.
  • The 5-year median for Change in Cash is $172769.0 (2021), against an average of -$896738.9.
  • The largest YoY upside for Change in Cash was 666.9% in 2022 against a maximum downside of 5879.04% in 2022.
  • A 5-year view of Change in Cash shows it stood at $1.2 million in 2021, then crashed by 81.93% to $216432.0 in 2022, then crashed by 1657.9% to -$3.4 million in 2023, then surged by 114.81% to $499430.0 in 2024, then plummeted by 851.27% to -$3.8 million in 2025.
  • Per Business Quant, the three most recent readings for CPIX's Change in Cash are -$3.8 million (Q4 2025), -$890536.0 (Q3 2025), and $978868.0 (Q2 2025).